The Scientist - Home

From rare diseases to chronic conditions, epigenetic editing unlocks new ways to control gene activity without altering the genetic code.

Developing next-generation liquid biopsies, this postdoc blends spectroscopy and AI to improve cancer detection and prognosis.

The end of the shutdown did not resolve the uncertainty facing US researchers, who continue to navigate delays and budget constraints that slow scientific progress.

Erythropoietin, the protein that drives red blood cell formation, also induces tolerance in dendritic cells, leading to the development of regulatory T cells.

Sequencing diverse populations revealed over 41,000 transcripts missing in Eurocentric references, exposing ancestry bias that limits insights into global disease risk.

Anxiety and insomnia don’t just affect mood. Researchers found that these conditions can reduce natural killer cell counts, possibly compromising immune strength.

Survey data showed that hoarding research topics and resources, termed the Gollum effect, has a lasting impact on trainees and perpetuates a toxic research culture.

From microglia reprogramming to immune cell-based diagnostics, 2025 was a big year for breakthroughs in cell biology.

This postdoc investigates pathways that drive neuromuscular disorders to uncover therapeutic possibilities.

People with cancer receiving immunotherapy earlier in the day survived longer, suggesting that adjusting treatment timing may improve outcomes.

Shining near-infrared light on a person’s skin helped scientists accurately track his blood glucose levels, offering a potential noninvasive way to monitor diabetes.

This postdoc works to decode virulence regulation in multidrug-resistant bacteria to inform next-generation antimicrobial development.